abstract |
"combination of regorafenib and acetylsalicylic acid for cancer treatment". The present invention relates to pharmaceutical compositions and combinations comprising regorafenib and acetylsalicylic acid, or a pharmaceutically acceptable hydrate, solvate, metabolite or salt thereof or a polymorph thereof, for the treatment, prevention or management of diseases and conditions, including hyperproliferative disorders such as like cancer in humans and other mammals. |